FENC EBITDA Growth
Fennec Pharmaceuticals Inc · EBITDA Growth
FENC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported71.68%period ending
FENC TTM EBITDA YoY % (-23.16% → 71.68%)
Year-over-year change
High-resolution chart · PNG
FENC ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 71.6788% | |
| 35.4926% | |
| -255.3356% | |
| -200.1341% | |
| -212.2809% | |
| -239.544% | |
| 138.8062% | |
| 122.316% | |
| 131.5707% | |
| 130.7068% | |
| 45.2606% | |
| 20.0517% | |
| -38.3245% | |
| -49.9069% | |
| -31.3198% | |
| -29.1062% | |
| 6.2955% | |
| 15.7845% | |
| 5.6293% | |
| 12.6477% | |
| -28.6771% | |
| -34.9901% | |
| -40.103% | |
| -48.728% | |
| -5.5779% | |
| -26.2389% | |
| -28.7% | |
| -30.9204% | |
| -51.8293% | |
| -44.8116% | |
| -45.4179% | |
| -70.5124% | |
| -123.6364% | |
| -143.0364% | |
| -142.1108% | |
| -145.2548% | |
| -93.1707% | |
| -68.4989% | |
| -51.9048% | |
| -249.0798% | |
| -119.7213% | |
| -43.9878% | |
| -35.0965% | |
| 33.1282% | |
| 56.032% | |
| 37.9896% | |
| 33.9783% | |
| 83.4634% | |
| 56.6408% | |
| 53.6222% | |
| -60.896% | |
| -168.7981% | |
| -158.3313% | |
| -154.2637% | |
| -128.117% | |
| 355.592% | |
| 352.255% | |
| 258.1815% | |
| 200.3428% | |
| 2.2164% | |
| -28.6156% | |
| -444.274% | |
| -82.0593% | |
| 38.8006% | |
| 70.6603% | |
| 91.3566% | |
| 81.3147% | |
| 60.722% | |
| 38.7065% | |
| 20.8686% | |
| 1.9717% | |
| 8.6226% | |
| 14.9519% | |
| 18.0389% | |
| 15.8525% | |
| 19.8139% | |
| 10.0801% | |
| 8.5089% | |
| 9.9326% | |
| -11.5675% | |
| -17.9853% | |
| -35.4997% | |
| -37.2013% | |
| -108.321% | |
| -131.2002% | |
| -127.6559% | |
| -147.1041% | |
| -71.7638% | |
| -38.8943% | |
| -28.6649% | |
| -24.365% | |
| -18.3868% | |
| -26.3813% | |
| 6.2751% | |
| -3.1415% | |
| -0.0312% | |
| -23.1583% |